Karen L. Smith is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 24,807 shares of AUPH, which is worth approximately $197,215. The most recent transaction as insider was on Nov 21, 2024, when has been sold 12,135 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.8K
0% 3M change
n/a 12M change
Total Value Held $197,215

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
BUY
Grant, award, or other acquisition
-
12,135 Added 32.85%
24,807 Common Shares
Nov 11 2024
SELL
Open market or private sale
$44,181 $8.43 p/Share
5,241 Reduced 29.26%
12,672 Common Stock
Nov 08 2024
BUY
Exercise of conversion of derivative security
-
17,913 Added 50.0%
17,913 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
EBS
Emergent BioSolutions Inc. Healthcare
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
CRTX
Cortexyme, Inc. Healthcare
SKYE
Skye Bioscience, Inc. Healthcare
CNTX
Context Therapeutics Inc. Healthcare
KLS

Karen L. Smith

Director
Gaithersburg,, MD

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if
Any

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH